Cryopreservation involves preserving living cells and tissues at extremely low temperatures, usually using liquid nitrogen at -196°C. At such low temperatures, any biological activity including cell division and metabolic processes is effectively stopped. This allows long-term storage of biological specimens such as human eggs, sperm, embryos, and stem cells for future use in fertility...
The global tissue banking market is estimated to be valued at US$ 1.81 Bn in 2023 and is expected to exhibit a CAGR of 10% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
SWOT Analysis:
Strength: The tissue banking market has seen strong growth in recent years due to the rising prevalence of chronic diseases...
Tissue banking involves the storage of various types of tissues and organs for future therapeutic applications. The banking of tissues aids in replacing damaged organs and tissues. Some key advantages associated with tissue banking are: it allows human tissues and organs to be preserved for future use in transplants and medical therapies; it encourages organ donation by allowing safe and...
Key TakeawaysKey players in the tissue banking market include Lonza, Thermo Fisher Scientific, Beckman Coulter, Custom Biogenic Systems and others. These key players are focusing on expanding their tissue banking facilities across major markets to cater to the growing demand.The demand for tissue banking is significantly growing majorly due to the rising prevalence of chronic diseases and...